On November 8, 2023, the U.S. Food and Drug Administration (FDA) issued a guidance document titled "Guidance for Industry: Compliance Policy for Cosmetic Product Facility Registration and Cosmetic Product Listing". This Guidance represents the current thinking of the FDA on this topic. It does not establish any rights for any person and is not binding on FDA or the public.

The Guidance consists of three parts, as shown below:

1. Introduction

2. Background

3. Discussion